Dose of relief
Are generic drugs just what the cost-cutters ordered? As healthcare prices spiral upward, some are encouraged by an emerging trend: Key drugs are losing patent protection. Now they look to the FDA to unclog the approval pipeline for generics.
WASHINGTON -- They're not sexy. They're not the darlings of multimillion-dollar advertising campaigns. But, generic drugs account for more than half of prescriptions written and, with the advent of the Medicare prescription drug benefit, members of Congress want to tap generics' savings potential. (Full article: 1021 words)
This article is available in our archives:
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass